Le Lézard
Classified in: Health
Subject: SVY

Global Rheumatoid Arthritis Drugs Markets 2018-2022 Featuring Abbvie, Amgen, Bristol-Myers Squibb , F. Hoffmann-La Roche & Pfizer


DUBLIN, March 21, 2018 /PRNewswire/ --

The "Drugs for Rheumatoid Arthritis: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.

Report Includes:

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Drugs for Rheumatoid Arthritis Market Characteristics

4 Drugs for Rheumatoid Arthritis Market Size and Growth

5 Drugs for Rheumatoid Arthritis Market Trends and Strategies

6 PESTLE Analysis

7 Drugs for Rheumatoid Arthritis Market Segmentation

8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis

9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors

10 Asia-Pacific Drugs for Rheumatoid Arthritis Market

11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis

12 Western Europe Drugs for Rheumatoid Arthritis Market

13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

14 Eastern Europe Drugs for Rheumatoid Arthritis Market

15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

16 North America Drugs for Rheumatoid Arthritis Market

17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis18 South America Drugs for Rheumatoid Arthritis Market

19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis

20 Middle East Drugs for Rheumatoid Arthritis Market

21 Africa Drugs for Rheumatoid Arthritis Market

22 Drugs for Rheumatoid Arthritis Market Customer Information

23 Drugs for Rheumatoid Arthritis Market Competitive Landscape

24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market

25 Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/qd8s65/global_rheumatoid?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...

at 09:05
Adolescence isn't just a phase; it's a time of unparalleled growth and an opportunity for developing strengths that will influence our adult lives. Recognizing the potential of this developmental stage, Committee for Children a global nonprofit and...

at 09:00
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...

at 09:00
LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies,...



News published on and distributed by: